نتایج جستجو برای: her2 amplification

تعداد نتایج: 71537  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Harry H Yoon Qian Shi William R Sukov Anne E Wiktor Maliha Khan Christopher A Sattler Axel Grothey Tsung-Teh Wu Robert B Diasio Robert B Jenkins Frank A Sinicrope

PURPOSE We examined the frequency, tumor characteristics, and prognostic impact of HER2 protein expression and gene amplification in patients with curatively resected esophageal adenocarcinoma (EAC). EXPERIMENTAL DESIGN HER2 expression was analyzed by immunohistochemistry (IHC) in surgical EAC specimens (n = 713). Gene amplification was examined by FISH in a large subset (n = 344). Most tumor...

2017
Jan Trøst Jørgensen Karsten Bork Nielsen Gitte Kjærsgaard Anna Jepsen Jens Mollerup

Background: HER2 serves as an important therapeutic target in gastroesophageal cancer. Differences in HER2 gene signal distribution patterns can be observed at the tissue level, but how it influences the HER2 amplification status has not been studied so far. Here, we investigated the link between HER2 amplification and the different types of gene signal distribution. Methods: Tumor samples from...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2014
Nasser Rakhshani Elham Kalantari Hadi Bakhti Masoud Reza Sohrabi Mitra Mehrazma

BACKGROUND Amplification and overexpression of human epidermal growth factor receptor 2 (HER2 / neu) oncogene has considerable prognostic value in breast and gastric cancers. This study aimed to evaluate the frequency, overexpression pattern, clinical significance, and concordance between the results for protein expression and gene amplification of HER-2/neu in gastric and gastro-esophageal jun...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Elizabeth A Mittendorf Yun Wu Maurizio Scaltriti Funda Meric-Bernstam Kelly K Hunt Shaheenah Dawood Francisco J Esteva Aman U Buzdar Huiqin Chen Sameena Eksambi Gabriel N Hortobagyi Jose Baselga Ana M Gonzalez-Angulo

PURPOSE To evaluate HER2 status in residual tumor identified at the time of surgery in patients not achieving a pathologic complete response (pCR) and to determine the effect of alterations in HER2 status on recurrence-free survival (RFS). EXPERIMENTAL DESIGN Clinicopathologic data for patients with HER2-overexpressing breast cancer receiving neoadjuvant therapy with a taxane, anthracycline, ...

2015
Rocio Vicario Vicente Peg Beatriz Morancho Mariano Zacarias-Fluck Junjie Zhang Águeda Martínez-Barriocanal Alexandra Navarro Jiménez Claudia Aura Octavio Burgues Ana Lluch Javier Cortés Paolo Nuciforo Isabel T. Rubio Elisabetta Marangoni James Deeds Markus Boehm Robert Schlegel Josep Tabernero Rebecca Mosher Joaquín Arribas Anna Sapino

A chromosomal region that includes the gene encoding HER2, a receptor tyrosine kinase (RTK), is amplified in 20% of breast cancers. Although these tumors tend to respond to drugs directed against HER2, they frequently become resistant and resume their malignant progression. Gene amplification in double minutes (DMs), which are extrachromosomal entities whose number can be dynamically regulated,...

Journal: :Carcinogenesis 2009
Kotoe Terada Eriko Okochi-Takada Sadako Akashi-Tanaka Kazuaki Miyamoto Kiyomi Taniyama Hitoshi Tsuda Kiyoshi Asada Michio Kaminishi Toshikazu Ushijima

The presence of frequent methylation of CpG islands (CGIs), designated as the CpG island methylator phenotype in some cancers, is associated with distinct clinicopathological characteristics, including gene amplification, in individual tumor types. Amplification of HER2 in human breast cancers is an important prognostic and therapeutic target, but an association between HER2 amplification and f...

Journal: :Cancer research 1992
E M Berns J G Klijn W L van Putten I L van Staveren H Portengen J A Foekens

Amplification of the c-myc and HER2/neu genes was found in 20 and 23%, respectively, of primary breast cancer tissues derived from 282 patients (median follow-up, 74 months). c-myc amplification was observed more frequently in larger tumors (P = 0.01) and in lymph node-positive patients (P = 0.01) but was not associated with age, menopausal status, or with differentiation grade or steroid recep...

2017
Basim Mohammed Khashman Safana Abdul-Sattar

Background: Breast cancer is the most common malignancy among women worldwide.The human epidermal growth factor receptor (HER) is a transmembrane receptor in the epidermal growth factor (EGF) receptor family located at the long arm of human chromosome 17 (17q12). Diagnostic assays for HER2 in breast cancer provide important prognostic information and independently help guide management by ident...

2014
An Na Seo Yoonjin Kwak Duck-Woo Kim Sung-Bum Kang Gheeyoung Choe Woo Ho Kim Hye Seung Lee

This study aimed at determining the incidence and clinical implications of HER2 status in primary colorectal cancer (CRC). HER2 status was investigated in two retrospective cohorts of 365 consecutive CRC patients (cohort 1) and 174 advanced CRC patients with synchronous or metachronous distant metastasis (cohort 2). HER2 status was determined by performing dual-color silver in-situ hybridizatio...

2010
M. Laé J. Couturier S. Oudard F. Radvanyi P. Beuzeboc A. Vieillefond

BACKGROUND This study assessed the human epidermal growth factor receptor-2 (HER2) protein expression and its relationship with gene amplification in invasive bladder carcinoma, using the same criteria than for breast cancer. PATIENTS AND METHODS In 1005 patients, paraffin-embedded tissues of transurethral resection or cystectomy were evaluated by immunohistochemistry (IHC), using antibodies ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید